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ABSTRACT 
Oncolytic viruses have been extensively evaluated for anticancer therapy because this virus 
preferentially infects cancer cells without interfering with normal cells. Newcastle Disease 
Virus (NDV) is an avian virus and one of the intensively studied oncolytic viruses affecting 
many types of cancer including glioma. Nevertheless, the capability of NDV infection on 
heterogeneous glioma tissue in a cerebrospinal fluid atmosphere has never been reported. 
Recently, Rac1 is reported to be required for efficient NDV replication in human cancer cells 
and established a link between tumourigenesis and sensitivity to NDV. Rac1 is a member of 
the Rho GTPases involved in the regulation of the cell migration and cell-cycle progression. 
Rac1 knockdown leads to significant inhibition of viral replication. In this work, we 
demonstrated that NDV treatment led to significant reduction of tumour tissue viability of 
freshly isolated heterogeneous human brain tumour slice, known as an ex vivo glioma acute 
slice (EGAS). Analysis of gene expression indicated that reduced tissue viability was 
associated with downregulation of Rac1. However, the viability reduction was not persistent. 
We conclude that NDV treatment induced EGAS viability suppression, but subsequent 
downregulation of Rac1 gene may reduce the NDV replication and lead to regrowth of EGAS 
tissue. 
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